Neoplasms, Glandular and Epithelial
-
Subject Areas on Research
-
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.
-
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
-
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
-
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
-
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.
-
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
-
A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy.
-
A targeted genetic association study of epithelial ovarian cancer susceptibility.
-
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
-
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
-
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
-
ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas.
-
Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.
-
Antiangiogenic therapies in epithelial ovarian cancer.
-
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
-
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
-
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
-
Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).
-
Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.
-
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
-
Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
-
BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
-
Bladder cancer. Clinical guidelines in oncology.
-
Carcinoma of the esophagus with mixed basaloid squamous and glandular differentiation: a distinct histological presentation.
-
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
-
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
-
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
-
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
-
Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissues.
-
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
-
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
-
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
-
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.
-
Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma.
-
Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.
-
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.
-
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.
-
Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.
-
Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.
-
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
-
Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
-
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
-
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.
-
Epithelial ovarian cancer.
-
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
-
Epithelioid and epithelial neoplasms of bone.
-
European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry.
-
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.
-
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
-
Familial pancreatic cancer.
-
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.
-
Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support.
-
Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival.
-
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
-
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
-
Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.
-
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
-
Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation.
-
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.
-
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
-
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
-
In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry.
-
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
-
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
-
Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
-
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
-
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.
-
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
-
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.
-
Molecular approaches to prevention and detection of epithelial ovarian cancer.
-
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.
-
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
-
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
-
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
-
Ovarian cancer risk associated with inherited inflammation-related variants.
-
Ovarian cancer. Clinical practice guidelines in oncology.
-
PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation.
-
Pancreatoblastoma in a teenage patient.
-
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
-
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
-
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
-
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
-
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
-
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
-
Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
-
Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: A SEER-MHOS study.
-
Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model.
-
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.
-
Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
-
Primary chemotherapy in epithelial ovarian cancer.
-
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
-
Prospective grading of neoplastic change in rat esophagus epithelium using angle-resolved low-coherence interferometry.
-
Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.
-
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
-
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
-
Recreational physical activity and ovarian cancer risk and survival.
-
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
-
Reduction of ovarian and oviductal cancers in calorie-restricted laying chickens.
-
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
-
Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
-
Role of salpingectomy at the time of urogynecologic surgery.
-
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
-
Targeting ovarian cancer-initiating cells.
-
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer.
-
The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.
-
The costs of adding laparoscopy to the management of advanced stage epithelial ovarian cancer.
-
The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
-
The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
-
The rise of genomic profiling in ovarian cancer.
-
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
-
The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer.
-
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.
-
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
-
Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
-
Yin yang 1 modulates taxane response in epithelial ovarian cancer.
-
Keywords of People